PubIndex
Search
Leaderboards
Bookmark
My Library
Sign in
Back
Cell Signaling Technology
Phospho-SMAD2 (Ser245/250/255) Antibody
#3104 · $366
100
Citing papers
14k
Combined citations
Copy product info
Export PDF dossier
Supplier page
Find this product
Research areas
Cancer-related molecular mechanisms research
8
Neurogenesis and neuroplasticity mechanisms
8
Epigenetics and DNA Methylation
7
MicroRNA in disease regulation
7
Endoplasmic Reticulum Stress and Disease
6
RNA modifications and cancer
6
Cancer, Hypoxia, and Metabolism
5
Cancer-related Molecular Pathways
5
Papers citing this product
1
The Time of Prenatal Immune Challenge Determines the Specificity of Inflammation-Mediated Brain and Behavioral Pathology
Journal of Neuroscience
·
2006
·
774 cit.
·
DOI
2
A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
The EMBO Journal
·
2012
·
772 cit.
·
DOI
3
RIP1 autophosphorylation is promoted by mitochondrial ROS and is essential for RIP3 recruitment into necrosome
Nature Communications
·
2017
·
596 cit.
·
DOI
4
A bioprosthetic ovary created using 3D printed microporous scaffolds restores ovarian function in sterilized mice
Nature Communications
·
2017
·
520 cit.
·
DOI
5
Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing
Oncotarget
·
2013
·
397 cit.
·
DOI
6
Protein design and variant prediction using autoregressive generative models
Nature Communications
·
2021
·
347 cit.
·
DOI
7
Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling
Journal of Clinical Investigation
·
2003
·
306 cit.
·
DOI
8
MiR-26b, Upregulated in Alzheimer's Disease, Activates Cell Cycle Entry, Tau-Phosphorylation, and Apoptosis in Postmitotic Neurons
Journal of Neuroscience
·
2013
·
291 cit.
·
DOI
9
A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti–PD-1 immunotherapy
Journal of Clinical Investigation
·
2020
·
248 cit.
·
DOI
10
Preclinical characterization of abemaciclib in hormone receptor positive breast cancer
Oncotarget
·
2017
·
196 cit.
·
DOI
Show 90 more papers
Feedback
Phospho-SMAD2 (Ser245/250/255) Antibody — Evidence — PubIndex